Akaza Bioscience Limited (11366292) is a private limited with share capital incorporated on 16/05/2018 (7 years old) and registered in northampton, NN15JF. The company operates under SIC code 72110 and is classified as Unknown.
Liquidation Voluntary Members Return Of Final Meeting
Category:Insolvency
Date:15-10-2025
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:20-12-2024
Liquidation Voluntary Appointment Of Liquidator
Category:Insolvency
Date:20-12-2024
Resolution
Category:Resolution
Date:20-12-2024
Liquidation Voluntary Declaration Of Solvency
Category:Insolvency
Date:20-12-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:25-09-2024
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:25-09-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:10-07-2024
Accounts With Accounts Type Unaudited Abridged
Category:Accounts
Date:31-12-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-11-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-11-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:05-07-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:07-10-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:22-07-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:24-06-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:01-04-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:01-04-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:01-04-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:01-04-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:04-10-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:20-05-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-12-2020
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:16-09-2020
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:15-05-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:17-03-2020
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:26-09-2019
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:05-06-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-05-2019
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:28-05-2019
Change Person Director Company With Change Date
Category:Officers
Date:28-05-2019
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:28-05-2019
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:28-05-2019
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:28-05-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:12-04-2019
Capital Name Of Class Of Shares
Category:Capital
Date:27-03-2019
Capital Allotment Shares
Category:Capital
Date:27-03-2019
Resolution
Category:Resolution
Date:27-03-2019
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:12-03-2019
Capital Alter Shares Subdivision
Category:Capital
Date:13-02-2019
Incorporation Company
Category:Incorporation
Date:16-05-2018
Innovate Grants
2
This company received a grant of £2671548.99 for Proof Of Concept Clinical Trial For Akaza Biosciences’ Resatorvid In Acute On Chronic Liver Failure Patients. The project started on 01/04/2019 and ended on 31/08/2021.
This company received a grant of £160398.0 for Proof Of Concept Clinical Trial For Akaza Biosciences’ Resatorvid In Acute On Chronic Liver Failure Patients. The project started on 01/06/2020 and ended on 30/11/2020.
Risk Assessment
not scored
International Score
Accounts
Typetotal exemption full
Due Date31/03/2026
Filing Date25/09/2024
Latest Accounts30/06/2024
Trading Addresses
Office 2, 295A Birchfield Road, Birmingham, West Midlands, B203BX
Suite 501 Unit 2, 94A Wycliffe Road, Northampton, Nn1 5Jf, NN15JFRegistered